Lomecel-B

bone marrow-derived mesenchymal stromal cells · Longeveron Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Lomecel-B, covering 2022-11-04 to 2025-06-25. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial. [Phase 2]

See pricing